<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03157856</url>
  </required_header>
  <id_info>
    <org_study_id>38RC17.019</org_study_id>
    <nct_id>NCT03157856</nct_id>
  </id_info>
  <brief_title>Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection</brief_title>
  <acronym>Bio-Prost</acronym>
  <official_title>Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TIMC-IMAG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Investigation Centre for Innovative Technology Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we aim to evaluate the feasibility of anti-PSMA labelling to detect
      post-operative prostatic tissues by two ex vivo fluorescence techniques. We will evaluate the
      feasibility and detection of anti-PSMA labelling by:

        1. / the FEMTO-ST institute medical device,

        2. / the confocal microscope that will be used to measure fluorescence spectra of
           biological samples.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this protocol, 12 patients will be included.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the fluorescence obtained using the FEMTO-ST device and the confocal microscope of anti-PSMA marked fresh prostate biopsies, for prostatic and non-prostatic tissue, as identified by anatomo-pathology (gold standard).</measure>
    <time_frame>14 months</time_frame>
    <description>Fluorescence measurements obtained using the FEMTO-ST medical device and the confocal microscope.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of the fluorescence obtained using the FEMTO-ST device and the confocal microscope of anti-PSMA marked fresh prostate biopsies, for cancerous and non-cancerous tissue, as identified by anatomo-pathology (gold standard).</measure>
    <time_frame>14 months</time_frame>
    <description>Fluorescence measurements obtained using the FEMTO-ST medical device and the confocal microscope.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Cancer Prostate</condition>
  <arm_group>
    <arm_group_label>Experimental: fluorescence assessment</arm_group_label>
    <description>Medical device: Use of the FEMTO-ST institute medical device to detect prostatic and non prostatic tissue.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fluorescence assessment</intervention_name>
    <description>All subjects of the study are going to have a radical prostatectomy. The FEMTO-ST medical device is used on 3 fresh biopsies (2 healthy and 1 malignant) which will be prelevated from the resected prostate in order to determine the prostatic or non-prostatic nature of tissue.</description>
    <arm_group_label>Experimental: fluorescence assessment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with indication for radical prostatectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male patient over 18 years old

          -  patient with indication for radical prostatectomy

          -  patient with a rectal palpable nodule or targeted MRI positive biopsies or with at
             least 4 positive biopsies in a hemi-prostate.

               -  patient affiliated to French social security system or equivalent

               -  patient who have signed a non-opposition form

        Exclusion Criteria:

          -  patient with contraindication to radical prostatectomy

          -  patient with remedial prostatectomy

          -  patient with normal preoperative MRI or with absence of tumoral area

          -  patient with history of hormonal therapy

          -  person deprived of freedom by judicial or administrative decision

          -  person under legal protection

          -  person hospitalized for psychiatric care.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Luc Descotes, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Grenoble Alpes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean Luc Descotes, MD, PhD</last_name>
    <phone>33 476 765 922</phone>
    <email>JLDescotes@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>BOUDRY Isabelle, PhD</last_name>
    <phone>33 476 766 645</phone>
    <email>iboudry@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grenoble Alpes University Hospital - Urology department</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Grenoble Alpes University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Luc Descotes, MD, PhD</last_name>
      <phone>33 476 765 922</phone>
      <email>JLDescotes@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle Boudry, PhD</last_name>
      <phone>33 476 766 645</phone>
      <email>iboudry@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean Alexandre Long, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gaelle Fiard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>June 8, 2017</last_update_submitted>
  <last_update_submitted_qc>June 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fluorescence imaging technique</keyword>
  <keyword>Biopsies from resected prostate</keyword>
  <keyword>Medical device</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

